TY - JOUR
T1 - Hormone replacement therapy to improve left ventricular diastolic functions in healthy postmenopausal women
AU - Yildirir, A.
AU - Yarali, H.
AU - Kabakci, G.
AU - Aybar, F.
AU - Akgul, E.
AU - Bukulmez, O.
PY - 2001
Y1 - 2001
N2 - Objectives: To investigate the effects of estrogen and estrogen plus progesterone replacement therapy on left ventricular systolic and diastolic function parameters in healthy postmenopausal women. Methods: Forty-six healthy consecutive postmenopausal women were prospectively enrolled. Hormone replacement therapy (HRT), which was either 0.625 mg/day conjugated equine estrogen (CEE) alone, or with 2.5 mg/day medroxyprogesterone acetate (MPA) was administered depending on the hysterectomy status. Left ventricular systolic and diastolic function parameters were evaluated with echocardiography before and after 6 months of HRT. The paired t-test was used for statistical analysis. Results: Estrogen or estrogen plus progesterone did not significantly alter the left ventricular dimensions and systolic function parameters. However, significant improvements were noted in several diastolic function parameters including late diastolic mitral flow velocity, ratio of early to late mitral flow velocity and isovolumic relaxation time (P = 0.003, P = 0.001 and P = 0.005, respectively, for the CEE group; all P < 0.001 for the CEE + MPA group). Conclusions: Estrogen or estrogen plus progesterone replacement therapy may significantly improve left ventricular diastolic functions in healthy postmenopausal women.
AB - Objectives: To investigate the effects of estrogen and estrogen plus progesterone replacement therapy on left ventricular systolic and diastolic function parameters in healthy postmenopausal women. Methods: Forty-six healthy consecutive postmenopausal women were prospectively enrolled. Hormone replacement therapy (HRT), which was either 0.625 mg/day conjugated equine estrogen (CEE) alone, or with 2.5 mg/day medroxyprogesterone acetate (MPA) was administered depending on the hysterectomy status. Left ventricular systolic and diastolic function parameters were evaluated with echocardiography before and after 6 months of HRT. The paired t-test was used for statistical analysis. Results: Estrogen or estrogen plus progesterone did not significantly alter the left ventricular dimensions and systolic function parameters. However, significant improvements were noted in several diastolic function parameters including late diastolic mitral flow velocity, ratio of early to late mitral flow velocity and isovolumic relaxation time (P = 0.003, P = 0.001 and P = 0.005, respectively, for the CEE group; all P < 0.001 for the CEE + MPA group). Conclusions: Estrogen or estrogen plus progesterone replacement therapy may significantly improve left ventricular diastolic functions in healthy postmenopausal women.
KW - Diastolic functions
KW - Hormone replacement therapy
KW - Menopause
UR - http://www.scopus.com/inward/record.url?scp=0035212261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035212261&partnerID=8YFLogxK
U2 - 10.1016/S0020-7292(01)00469-6
DO - 10.1016/S0020-7292(01)00469-6
M3 - Article
C2 - 11728489
AN - SCOPUS:0035212261
SN - 0020-7292
VL - 75
SP - 273
EP - 278
JO - International Journal of Gynecology and Obstetrics
JF - International Journal of Gynecology and Obstetrics
IS - 3
ER -